Journal details
TRANSPLANTATION AND CELLULAR THERAPY
ELSEVIER SCIENCE INC · ISSN 2666-6375 · eISSN 2666-6367
SCIEScopusMEDLINEPubMed
Overview
TRANSPLANTATION AND CELLULAR THERAPY. ISSN 2666-6375 · eISSN 2666-6367. published by ELSEVIER SCIENCE INC. United States. Hematology · Immunology · Transplantation. impact factor 4.7 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 1,194 articles · 2025: 1,227 articles · 2024: 992 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of TRANSPLANTATION AND CELLULAR THERAPY?
The impact factor recorded for TRANSPLANTATION AND CELLULAR THERAPY is 4.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of TRANSPLANTATION AND CELLULAR THERAPY?
TRANSPLANTATION AND CELLULAR THERAPY is listed in CAS Zone 3.
Which databases index TRANSPLANTATION AND CELLULAR THERAPY?
TRANSPLANTATION AND CELLULAR THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed. Confirm on the journal website and the database itself before submitting.